Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.
Saved in:
| Title: | Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. |
|---|---|
| Authors: | García-Saenz JA; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Spera G; Translational Research in Oncology, Medical Affairs, Montevideo, Uruguay., Pollán M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Valencia, INCLIVA Instituto de Investigación Sanitaria, Universidad de Medicina de Valencia, Valencia, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Chan A; Curtin Medical School, Faculty of Health Sciences, Perth, Australia., Martín M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Guerrero-Zotano Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Calvo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Marín M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Consorci Sanitari de Terrassa, Terrassa, Spain., Chap L; Beverly Hills Cancer, Beverly Hills, Los Angeles, USA., Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland., Pienkowski T; Postgraduate Medical Education Center, Warsaw, Poland., Bee V; Translational Research in Oncology, Project Management, Paris, France., Casas M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Bezares S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Slamon D; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, California, Los Angeles, USA. |
| Source: | International journal of cancer [Int J Cancer] 2025 Aug 15; Vol. 157 (4), pp. 709-721. Date of Electronic Publication: 2025 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.35432 |
